News
Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...
British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...
In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy ...
AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing ...
Explore more
Biogen is investing $2 billion in its U.S. manufacturing footprint — but not in Massachusetts, where the drug company is ...
16h
The National on MSNAbu Dhabi vaccine hub opens in 'logistics milestone' for capitalOperations have begun at an Abu Dhabi vaccine distribution hub primed to deliver millions of doses each year as part of a mission to improve access to health care across the region. The logistics ...
StockStory.org on MSN9h
Why Privia Health (PRVA) Stock Is Up TodayShares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 3.4% in the morning session as investors ...
StockStory.org on MSN7h
Why Molina Healthcare (MOH) Shares Are Sliding TodayShares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 3.8% in the afternoon session after TD Cowen lowered ...
"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...
Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DoH, Abu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results